Neutral
●
PRNewsWire
●
vor 4 Monaten
BRIDGEWATER, N.J., Feb. 13, 2026 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that management will present at the following investor conferences: 46th Annual TD Cowen Healthcare Conference in Boston, on Monday, ...